M. Raghoebar

602 total citations
31 papers, 476 citations indexed

About

M. Raghoebar is a scholar working on Oncology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, M. Raghoebar has authored 31 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pharmacology and 7 papers in Psychiatry and Mental health. Recurrent topics in M. Raghoebar's work include Drug Transport and Resistance Mechanisms (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Epilepsy research and treatment (5 papers). M. Raghoebar is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Epilepsy research and treatment (5 papers). M. Raghoebar collaborates with scholars based in Netherlands, United States and Germany. M. Raghoebar's co-authors include J. Van Harten, M. Hugo de Vries, Wim B. van den Berg, C. A. M. van Ginneken, Marcel Levi, Jeffrey I. Weitz, Scott D. Berkowitz, Kenneth Todd Moore, Jerrold H. Levy and Dagmar Kubitza and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Life Sciences.

In The Last Decade

M. Raghoebar

30 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Raghoebar Netherlands 11 150 116 113 95 68 31 476
Michel Mallaret France 11 47 0.3× 21 0.2× 54 0.5× 50 0.5× 58 0.9× 37 549
Robert C. Wood United States 12 33 0.2× 29 0.3× 47 0.4× 24 0.3× 33 0.5× 29 411
Roberta Roberti Italy 12 52 0.3× 21 0.2× 31 0.3× 201 2.1× 103 1.5× 31 455
DOROTHY BUSFIELD United States 10 73 0.5× 10 0.1× 44 0.4× 18 0.2× 63 0.9× 13 426
Brian L. Lloyd Australia 13 260 1.7× 6 0.1× 48 0.4× 47 0.5× 60 0.9× 36 705
Sum Lam United States 11 45 0.3× 9 0.1× 88 0.8× 50 0.5× 23 0.3× 28 353
Shweta Anand India 13 93 0.6× 26 0.2× 24 0.2× 27 0.3× 8 0.1× 58 483
Manish D. Assar United States 8 348 2.3× 17 0.1× 28 0.2× 29 0.3× 10 0.1× 21 537
Wanli Zhang China 14 81 0.5× 20 0.2× 20 0.2× 39 0.4× 11 0.2× 45 541
Kristine C. Willett United States 12 39 0.3× 29 0.3× 41 0.4× 13 0.1× 15 0.2× 23 316

Countries citing papers authored by M. Raghoebar

Since Specialization
Citations

This map shows the geographic impact of M. Raghoebar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Raghoebar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Raghoebar more than expected).

Fields of papers citing papers by M. Raghoebar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Raghoebar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Raghoebar. The network helps show where M. Raghoebar may publish in the future.

Co-authorship network of co-authors of M. Raghoebar

This figure shows the co-authorship network connecting the top 25 collaborators of M. Raghoebar. A scholar is included among the top collaborators of M. Raghoebar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Raghoebar. M. Raghoebar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levi, Marcel, Kenneth Todd Moore, Dagmar Kubitza, et al.. (2014). Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. Journal of Thrombosis and Haemostasis. 12(9). 1428–1436. 159 indexed citations
2.
Olivier, Berend, et al.. (1994). Serenics. Birkhäuser Basel eBooks. 42. 167–308. 4 indexed citations
3.
Harten, J. Van, et al.. (1993). Pharmacokinetics of Fluvoxamine Maleate in Patients with Liver Cirrhosis after Single-Dose Oral Administration. Clinical Pharmacokinetics. 24(2). 177–182. 31 indexed citations
4.
Harten, J. Van, Lloyd Stevens, M. Raghoebar, et al.. (1992). Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function. Clinical Pharmacology & Therapeutics. 52(4). 427–435. 39 indexed citations
5.
Vries, M. Hugo de, et al.. (1992). Single and Multiple Oral Dose Fluvoxamine Kinetics in Young and Elderly Subjects. Therapeutic Drug Monitoring. 14(6). 493–498. 50 indexed citations
6.
Vries, M. Hugo de, P. de Koning, A. Grahnén, et al.. (1991). Dose-proportionality of eltoprazine. European Journal of Clinical Pharmacology. 41(5). 485–488. 6 indexed citations
7.
Raghoebar, M., et al.. (1991). Comparison of in vitro and in vivo release characteristics of acetaminophen from gradient matrix systems. Biopharmaceutics & Drug Disposition. 12(5). 367–373. 10 indexed citations
8.
Harten, J. Van, et al.. (1991). Bioavailability of fluvoxamine given with and without food. Biopharmaceutics & Drug Disposition. 12(8). 571–576. 14 indexed citations
9.
Raghoebar, M., et al.. (1990). THE METABOLITE PATTERNS OF ELTOPRAZINE IN MAN, DOG, RAT AND RABBIT. Drug metabolism and drug interactions. 8(1-2). 129–140. 2 indexed citations
10.
Olivier, Berend, et al.. (1990). ETHOPHARMACOLOGY: A CREATIVE APPROACH TO IDENTIFICATION AND CHARACTERISATION OF NOVEL PSYCHOTROPICS. Drug metabolism and drug interactions. 8(1-2). 11–30. 11 indexed citations
11.
Raghoebar, M., et al.. (1990). DISTRIBUTION OF RADIOACTIVELY LABELLED ELTOPRAZINE IN RAT AND DOG. Drug metabolism and drug interactions. 8(1-2). 115–128. 2 indexed citations
12.
Harten, J. Van, et al.. (1990). PHARMACOKINETICS OF ELTOPRAZINE IN HEALTHY SUBJECTS. Drug metabolism and drug interactions. 8(1-2). 149–158. 5 indexed citations
13.
Olivier, Berend, et al.. (1990). POSSIBLE CLINICAL APPLICATIONS OF SERENICS AND SOME IMPLICATIONS OF THEIR PRECLINICAL PROFILE FOR THEIR CLINICAL USE IN PSYCHIATRIC DISORDERS. Drug metabolism and drug interactions. 8(1-2). 159–186. 3 indexed citations
14.
Raghoebar, M., et al.. (1989). Modes of Association of Indometacin with Human Polymorphonuclear Leucocytes. Pharmacology. 39(6). 350–361. 7 indexed citations
15.
Raghoebar, M., et al.. (1988). Chloroquine interaction with inflammatory human polymorphonuclear leucocytes. Inflammation Research. 24(3-4). 331–342. 4 indexed citations
16.
Raghoebar, M., Wim B. van den Berg, & C. A. M. van Ginneken. (1988). Mechanisms of cell association of some non-steroidal anti-inflammatory drugs with isolated leucocytes. Biochemical Pharmacology. 37(7). 1245–1250. 6 indexed citations
17.
Raghoebar, M., et al.. (1987). An in vitro approach to study cellular kinetics of drugs. Journal of Pharmacological Methods. 18(3). 239–251. 5 indexed citations
18.
Raghoebar, M., et al.. (1987). The cellular association of sodium salicylate and indomethacin in peritoneal fluid of ascites bearing mice. Inflammation Research. 22(3-4). 314–323. 4 indexed citations
19.
Raghoebar, M., et al.. (1986). Mechanisms of cell association of chloroquine to leucocytes.. Journal of Pharmacology and Experimental Therapeutics. 238(1). 302–306. 25 indexed citations
20.
Raghoebar, M., et al.. (1984). Association of sodium salicylate to isolated leucocytes. Biochemical Pharmacology. 33(18). 2937–2941. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Mallaret Breakdown of academic impact, for papers by Robert C. Wood Breakdown of academic impact, for papers by Roberta Roberti Breakdown of academic impact, for papers by DOROTHY BUSFIELD Breakdown of academic impact, for papers by Brian L. Lloyd Breakdown of academic impact, for papers by Sum Lam Breakdown of academic impact, for papers by Shweta Anand Breakdown of academic impact, for papers by Manish D. Assar Breakdown of academic impact, for papers by Wanli Zhang Breakdown of academic impact, for papers by Kristine C. Willett
Rankless by CCL
2026